Skip to content

Prednisone/Prednisolone

DRUG18 trials

Sponsors

Pfizer, Cougar Biotechnology, Inc., Hoffmann-La Roche, Organon and Co, Bayer

Conditions

Advanced Solid TumorAsthmaB-Cell LymphomaChronic Lymphocytic LymphomaDiffuse Large B-cell Lymphoma (DLBCL)Follicular LymphomaFollicular Lymphoma (FL)Generalized Myasthenia Gravis

Phase 1

Phase 2

Phase 3

Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)
TerminatedNCT00562965
PfizerLymphoma, Follicular
Start: 2007-11-30End: 2011-04-30Updated: 2018-01-09
Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
CompletedNCT00638690
Cougar Biotechnology, Inc.Prostatic Neoplasms
Start: 2008-05-31End: 2012-10-31Updated: 2014-04-30
A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma
CompletedNCT01200758
Hoffmann-La RocheNon-Hodgkin's Lymphoma
Start: 2011-02-15End: 2017-10-31Updated: 2018-11-27
Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms
CompletedNCT02043678
BayerProstatic Neoplasms
Start: 2014-03-30End: 2024-02-08Updated: 2025-02-19
Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris
TerminatedNCT02613910
GlaxoSmithKlinePemphigus
Start: 2015-12-23End: 2016-03-23Updated: 2017-06-14
Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)
CompletedNCT02741271
Organon and CoAsthma
Start: 2016-05-11End: 2017-12-04Updated: 2024-05-16
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
CompletedNCT03072238
Hoffmann-La RocheMetastatic Prostate Cancer
Start: 2017-06-30End: 2024-04-24Updated: 2025-06-06
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
RecruitingNCT06091254
Regeneron PharmaceuticalsFollicular Lymphoma (FL)
Start: 2023-12-12End: 2029-11-03Target: 822Updated: 2026-03-11
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Active, not recruitingNCT06091865
Regeneron PharmaceuticalsDiffuse Large B-cell Lymphoma (DLBCL)
Start: 2023-12-13End: 2029-09-02Target: 904Updated: 2026-02-05
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
RecruitingNCT06911502
CelgeneFollicular Lymphoma
Start: 2025-07-28End: 2030-07-31Target: 400Updated: 2025-12-05
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Not yet recruitingNCT07365995
BioNTech SEMetastatic Castration-resistant Prostate Cancer
Start: 2026-03-01End: 2031-02-01Target: 736Updated: 2026-01-26

Phase 4

Unknown Phase

Related Papers

47 more papers not shown